Geode Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.8M | Buy |
|
|||||
|
2025
Q1 | $68.9M | Buy |
|
|||||
|
2024
Q4 | $53.2M | Buy |
|
|||||
|
2024
Q3 | $61.9M | Buy |
|
|||||
|
2024
Q2 | $47.5M | Buy |
|
|||||
|
2024
Q1 | $37.4M | Buy |
|
|||||
|
2023
Q4 | $28.6M | Buy |
|
|||||
|
2023
Q3 | $19.7M | Buy |
|
|||||
|
2023
Q2 | $29.8M | Buy |
|
|||||
|
2023
Q1 | $21.3M | Buy |
|
|||||
|
2022
Q4 | $9.6M | Buy |
|
|||||
|
2022
Q3 | $6.97M | Buy |
|
|||||
|
2022
Q2 | $6.5M | Sell |
|
|||||
|
2022
Q1 | $19.7M | Buy |
|
|||||
|
2021
Q4 | $26.6M | Buy |
|
|||||
|
2021
Q3 | $12.9M | Buy |
|
|||||
|
2021
Q2 | $32M | Buy |
|
|||||
|
2021
Q1 | $16.7M | Buy |
|
|||||
|
2020
Q4 | $10.2M | Buy |
|
|||||
|
2020
Q3 | $8.58M | Buy |
|
|||||
|
2020
Q2 | $6.5M | Buy |
|
|||||
|
2020
Q1 | $2.07M | Buy |
|
|||||
|
2019
Q4 | $1.91M | Buy |
|
|||||
|
2019
Q3 | $3.14M | Buy |
|
|||||
|
2019
Q2 | $2.47M | Buy |
|
|||||
|
2019
Q1 | $1.67M | Buy |
|
|||||
|
2018
Q4 | $792K | Sell |
|
|||||
|
2018
Q3 | $1.21M | Sell |
|
|||||
|
2018
Q2 | $846K | Sell |
|
|||||
|
2018
Q1 | $1.22M | Buy |
|
|||||
|
2017
Q4 | $2.91M | Buy |
|
|||||
|
2017
Q3 | $1.99M | Buy |
|
|||||
|
2017
Q2 | $1.21M | Buy |
|
|||||
|
2017
Q1 | $1.3M | Buy |
|
|||||
|
2016
Q4 | $2.19M | Buy |
|
|||||
|
2016
Q3 | $1.96M | Buy |
|